Organisation paid for research Program year 2025 Source: CMS Open Payments

GCM Medical Group, PSC

Neither a doctor nor a teaching hospital

Research payments

$1,534,360

723 payments

Through program year 2025, GCM Medical Group, PSC is reported as receiving $1,534,360 in research payments, across 723 payments.

By program year

6 rows

Year	Kind	Amount	Payments
2025	Research	$11,020	7
2024	Research	$81,624	152
2023	Research	$111,318	220
2022	Research	$68,478	138
2021	Research	$248,931	4
2019	Research	$1,012,990	202

Breakdown

Who paid Research payments · program years 2019–2025

AbbVie, Inc. $1,012,990 202 payments
Amgen Inc. $249,847 5 payments
Alnylam Pharmaceuticals Inc. $114,142 462 payments
Moderna TX, Inc. $113,324 21 payments
Incyte Corporation $44,057 33 payments

Studies the money was for Research payments · program years 2019–2025

Psor-025/20200063 (Discreet) $248,931 4 payments
M15-554 $245,388 34 payments
M14-496 $213,397 26 payments
M15-925 $110,953 19 payments
M16-047 $107,065 16 payments
A Study to Evaluate Efficacy and Safety of ALN-AGT01 in Patients With Mild To-Moderate Hypertension (KARDIA-1) $100,478 351 payments
M15-572 $93,666 30 payments
M16-063 $81,423 13 payments
A Phase 2, Randomized, Observer-Blind, Placebo-Controlled, Dose Confirmation Study to Evaluate the Safety, Tolerability, and Immunogenicity of Lyophilized Zika Vaccine mRNA-1893 in Adults Aged 18-65 Years and Living in Endemic and Non Endemic Flavivi $64,041 14 payments
M13-538 $59,061 13 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.